Biogen enhances its portfolio and margins amidst market challenges and competition. Click here to find out why BIIB stock is ...

Biogen Inc. closed 41.04% below its 52-week high of $238.00, which the company achieved on July 12th.

The CPG Week podcast team discusses Bain & Company’s Insurgent Brands class of 2025, the similarities among new insurgent ...

Full-year results and business updateClinical proof of principle obtained in Phase I adjuvant head and neck cancer trial with individualized ...